Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Moving Up the Value Chain

By Pharmaceutical Processing | May 14, 2015

In-house legal departments across the pharmaceutical industry are being asked to manage ever-increasing risk and compliance challenges, as well as increasing litigation costs as cases increase. In fact, it has been estimated that 2014 saw a 25 percent rise in patent cases[i] – a critical driver of corporate revenue given that generic manufacturers that win patent cases can take over 65 percent of a pharmaceutical’s revenue base – and they win an estimated 70 percent of the time[ii].

At the same time, these legal departments are facing pressures familiar to all legal departments, regardless of industry: lowering overall legal spend and evolving from a company cost center into a strategic business partner. These requirements mean that the department has to do more with less, while increasing visibility, predictability, and responsiveness. 

Traditionally, however, in-house legal departments have not invested in building the skills, processes, and tools to support this evolution from a cost center into a true driver of business value for the enterprise. One way to think about this evolution is to view legal departments as falling in different stages on a maturity curve:

  • Stage 1: Legal as a Cost Center.
    • A department that primarily reacts in mitigating known risks.
    • Has undefined and/or inefficient business processes.
    • Operates as an independent “silo” with infrequent collaboration with other departments.
    • Has a reputation as simply a cost of doing business.
  • Stage 2: Legal as a Tactical Success.
    • Department that is cost-efficient.
    • Uses predictable, repeatable processes to respond to internal and external needs.
    • Is viewed as a valued partner that is often brought in by the business to facilitate solutions.
  • Stage 3: Legal as a Competitive Advantage.
    • Department that actually drives positive bottom‑line business results by optimizing legal spend and performance.
    • Operates with foresight to protect the company’s brand and reputation by preventing risks from becoming legal issues.
    • Leverages data to predict likely outcomes and support informed business decision making.

The best legal departments will be those that create lasting competitive advantages for their companies by embracing this change and moving up the value chain. At Mitratech, we have found that many legal departments beginning to embrace this new model through the implementation of key tactics, including:

  • Optimizing overall spend – moving beyond simply cutting legal costs to optimize spend for business outcomes even outside of the department.
  • Protecting intangible assets like corporate brand reputation proactively, in concert with strategic positioning.
  • Proactively mitigating risk in a way that increases business investment opportunities.
  • Facilitating decisions by predicting successful business outcomes – in addition to advising in a way that prevents legal risk.
  • Minimizing commercial friction to the point of being an accelerant of revenue.

Let’s examine one example of how these can be applied specifically in the pharmaceutical industry:

Example 1:

In a recent Inside Counsel article, the example of one pharmaceutical company that proactively mitigated risk and averted compliance issues through emerging legal technology was highlighted.  The article noted that “a major pharmaceutical company used data analytics available through e-discovery technology used in litigation and investigations to detect and avert potential liability relating to off-label marketing, unapproved patient populations, Sunshine Law compliance and unsupported product claims.

“The legal department interviewed subject-matter experts to gather the keywords, concepts and metadata necessary to construct a profile of documents requiring closer scrutiny. After sampling email and other unstructured data, the company used predictive, concept and relationship analytics, as well as email communication visualization to automatically segment the one percent of documents that indicated a potential compliance violation.”[iii]

This example demonstrates how proactively mitigating risk through the use of data and analytics enabled this pharmaceutical company to drive value to the business and lowered the risk of litigation costs.

What’s the lesson here? GCs must embrace their role as a driver of real competitive advantage and enterprise value. Legal departments cannot simply view themselves as a cost center. If one competitor is able to effectively apply these legal tactics in a way that their peer companies are not applying, they will win market share and drive shareholder value through an enhanced brand reputation, increased overall revenue and increased corporate profitability.


[i] PWC, 2014 Patent Litigation Study, 2014, p 2.
[ii] Kit R. Roane, Fortune Magazine: Generics’ new legal attack: Big Pharma’s aging patents, 2011.
[iii] Bill Schiefelbein and Anthony J. Diana, Inside Counsel: Data analytics as an emerging tool for compliance and legal risk management, 2015.
 
Lance Ellisor serves as VP of Product Management at Mitratech, where he is responsible for defining the company’s product strategy and roadmap in support of its mission to enable the world’s best-run legal departments.

 

Related Articles Read More >

Videojet
Why pharmaceutical companies are warming up to predictive maintenance
India
India curbs COVID-19 vaccine exports as infections rise
Pharmaceutical environment
Pharma’s been slow to adopt Industry 4.0 — but that could change
Honeywell Sparta Systems
Honeywell to acquire Sparta Systems for $1.3B

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards